|Short name: P792, generic name: Gadomeritol, preliminary trade name: Vistarem™, central moiety: Gd |
A macromolecular Gd-DOTA derivate under development as a MRI blood pool agent with rapid clearance. Phase II of the clinical trials on P792 (Guerbet SA) will make it possible to validate the performance of this agent in the fields of angiography, myocardial perfusion and tumor characterization.
• View the DATABASE results for 'P792' (2).
• View the NEWS results for 'P792' (1).
| News & More:|